{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:25:08Z","timestamp":1787167508184,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,29]]},"DOI":"10.7759\/cureus.78208","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:41:21Z","timestamp":1738186881000},"source":"Crossref","is-referenced-by-count":5,"title":["Mesalazine-Induced Myocarditis in Inflammatory Bowel Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Kiran","family":"Jhakri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moath","family":"Al-Shudifat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Sumra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Kocherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"5-Aminosalicylic acid-associated myocarditis and pericarditis: a narrative review","volume":"69","author":"Brown G","year":"2016","unstructured":"Brown G. 5-Aminosalicylic acid-associated myocarditis and pericarditis: a narrative review. Can J Hosp Pharm. 2016, 69:466-72.","journal-title":"Can J Hosp Pharm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43567","article-title":"Mesalamine - a revered drug for inflammatory bowel disease with detrimental effects on the lung and heart","volume":"15","author":"Chaudhry A","year":"2023","unstructured":"Chaudhry A, Noor J, Fatima G, Batool S, Noor R. Mesalamine - a revered drug for inflammatory bowel disease with detrimental effects on the lung and heart. Cureus. 2023, 15:e43567. 10.7759\/cureus.43567","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2021.152","article-title":"5-Aminosalicylic acid-induced myocarditis in a patient with atypical ulcerative colitis","volume":"79","author":"Song HY","year":"2022","unstructured":"Song HY, Seo GS. 5-Aminosalicylic acid-induced myocarditis in a patient with atypical ulcerative colitis. Korean J Gastroenterol. 2022, 79:31-4. 10.4166\/kjg.2021.152","journal-title":"Korean J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4104","article-title":"Myocarditis related to the use of mesalazine","volume":"14","author":"Kyriakou M","year":"2023","unstructured":"Kyriakou M, Sakellaropoulos S, Constantinides T, Chatzantonis G, Avraamides P, Mitsis A. Myocarditis related to the use of mesalazine. J Med Cases. 2023, 14:237-43. 10.14740\/jmc4104","journal-title":"J Med Cases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14010","article-title":"Cardiovascular manifestations in inflammatory bowel disease: a systematic review of the pathogenesis and management of pericarditis","volume":"13","author":"Patel RS","year":"2021","unstructured":"Patel RS, Rohit Reddy S, Llukmani A, et al.. Cardiovascular manifestations in inflammatory bowel disease: a systematic review of the pathogenesis and management of pericarditis. Cureus. 2021, 13:e14010. 10.7759\/cureus.14010","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.01.071","article-title":"Myocarditis and inflammatory bowel diseases: a single-center experience and a systematic literature review","volume":"376","author":"Giordani AS","year":"2023","unstructured":"Giordani AS, Candelora A, Fiacca M, et al.. Myocarditis and inflammatory bowel diseases: a single-center experience and a systematic literature review. Int J Cardiol. 2023, 376:165-71. 10.1016\/j.ijcard.2023.01.071","journal-title":"Int J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-020-01279-8","article-title":"Myocarditis: imaging up to date","volume":"125","author":"Liguori C","year":"2020","unstructured":"Liguori C, Farina D, Vaccher F, Ferrandino G, Bellini D, Carbone I. Myocarditis: imaging up to date. Radiol Med. 2020, 125:1124-34. 10.1007\/s11547-020-01279-8","journal-title":"Radiol Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20036","article-title":"A rare case of mesalazine-induced acute myocarditis in a 19-year-old female with ulcerative colitis","volume":"13","author":"Ali A","year":"2021","unstructured":"Ali A, Kumaravel Kanagavelu AS, Rahimi A, Mehmood Z, Tariq AB, Das T, Elmdaah A. A rare case of mesalazine-induced acute myocarditis in a 19-year-old female with ulcerative colitis. Cureus. 2021, 13:e20036. 10.7759\/cureus.20036","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytae458","article-title":"Mesalazine-induced myocarditis in a patient with ulcerative colitis: a case report","volume":"8","author":"Littlewood S","year":"2024","unstructured":"Littlewood S, Nikolou E, Aziz W, Anderson L. Mesalazine-induced myocarditis in a patient with ulcerative colitis: a case report. Eur Heart J Case Rep. 2024, 8:ytae458. 10.1093\/ehjcr\/ytae458","journal-title":"Eur Heart J Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228037","article-title":"Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis","volume":"12","author":"Dias T","year":"2019","unstructured":"Dias T, Santos A, Santos RM, Carvalho A. Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis. BMJ Case Rep. 2019, 12:e228037. 10.1136\/bcr-2018-228037","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-01","article-title":"JBI manual for evidence synthesis","year":"2024","unstructured":"JBI manual for evidence synthesis. Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z (ed). JBI, Adelaide, South Australia; 2024. 10.46658\/JBIMES-24-01"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/ERP-17-0044","article-title":"Mesalazine-induced myopericarditis in a patient with ulcerative colitis","volume":"5","author":"Asadi J","year":"2017","unstructured":"Asadi J, Bhandari SS, Ahmed N. Mesalazine-induced myopericarditis in a patient with ulcerative colitis. Echo Res Pract. 2017, 5:K1-5. 10.1530\/ERP-17-0044","journal-title":"Echo Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000587","article-title":"Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature","volume":"8","author":"Caio G","year":"2021","unstructured":"Caio G, Lungaro L, Caputo F, et al.. Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature. BMJ Open Gastroenterol. 2021, 8:e000587. 10.1136\/bmjgast-2020-000587","journal-title":"BMJ Open Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2024.024","article-title":"Perimyocarditis in a patient with ulcerative colitis treated with 5-aminosalicylic acid","volume":"83","author":"Lee HY","year":"2024","unstructured":"Lee HY, Baek DH. Perimyocarditis in a patient with ulcerative colitis treated with 5-aminosalicylic acid. Korean J Gastroenterol. 2024, 83:197-9. 10.4166\/kjg.2024.024","journal-title":"Korean J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9813893","article-title":"Myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis","volume":"2018","author":"Okoro KU","year":"2018","unstructured":"Okoro KU, Roby MD, Bankole AA. Myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis. Case Rep Med. 2018, 2018:9813893. 10.1155\/2018\/9813893","journal-title":"Case Rep Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2014.05.013","article-title":"Myopericarditis in a patient with ulcerative colitis treated with mesalamine\u2014case report and review of the literature","volume":"10","author":"Roczek M","year":"2014","unstructured":"Roczek M, Polak \u0141, Zieli\u0144ska M, Chi\u017cy\u0144ski K. Myopericarditis in a patient with ulcerative colitis treated with mesalamine\u2014case report and review of the literature. J Cardiol Cases. 2014, 10:104-7. 10.1016\/j.jccase.2014.05.013","journal-title":"J Cardiol Cases"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210689","article-title":"Cardiac MRI-confirmed mesalamine-induced myocarditis","volume":"2015","author":"Baker WL","year":"2015","unstructured":"Baker WL, Saulsberry WJ, Elliott K, Parker MW. Cardiac MRI-confirmed mesalamine-induced myocarditis. BMJ Case Rep. 2015, 2015:bcr2015210689. 10.1136\/bcr-2015-210689","journal-title":"BMJ Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-204818","article-title":"Ulcerative colitis-induced myocarditis","volume":"2014","author":"Gruenhagen B","year":"2014","unstructured":"Gruenhagen B, Alraies MC, Vakil KP, March SK. Ulcerative colitis-induced myocarditis. BMJ Case Rep. 2014, 2014:bcr2014204818. 10.1136\/bcr-2014-204818","journal-title":"BMJ Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3978","article-title":"Mesalamine-induced myocarditis in a young athlete: can he run again?","volume":"11","author":"Ibrahim A","year":"2019","unstructured":"Ibrahim A, Khalil C, Megaly M, Tawadros M, Mosleh W, Corbelli J. Mesalamine-induced myocarditis in a young athlete: can he run again?. Cureus. 2019, 11:e3978. 10.7759\/cureus.3978","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa120","article-title":"Myocarditis in Crohn's disease: a case report","volume":"4","author":"McGrath-Cadell L","year":"2020","unstructured":"McGrath-Cadell L, Bart NK, Lin L, Ghaly S, Holloway CJ. Myocarditis in Crohn's disease: a case report. Eur Heart J Case Rep. 2020, 4:1-6. 10.1093\/ehjcr\/ytaa120","journal-title":"Eur Heart J Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i11.3376","article-title":"Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis","volume":"21","author":"Fleming K","year":"2015","unstructured":"Fleming K, Ashcroft A, Alexakis C, Tzias D, Groves C, Poullis A. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis. World J Gastroenterol. 2015, 21:3376-9. 10.3748\/wjg.v21.i11.3376","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4250\/jcu.2016.24.2.163","article-title":"Successfully treated acute fulminant myocarditis induced by ulcerative colitis with extracorporeal life support and infliximab","volume":"24","author":"Kim HK","year":"2016","unstructured":"Kim HK, Kim KI, Jung SW, Mun HS, Cho JR, Lee N, Kang MK. Successfully treated acute fulminant myocarditis induced by ulcerative colitis with extracorporeal life support and infliximab. J Cardiovasc Ultrasound. 2016, 24:163-7. 10.4250\/jcu.2016.24.2.163","journal-title":"J Cardiovasc Ultrasound"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2022.02.008","article-title":"Acute myocarditis as first presentation of severe ulcerative colitis in a young man. Multidisciplinary management and long-term follow-up","volume":"26","author":"Piazza I","year":"2022","unstructured":"Piazza I, Burti C, Assolari A, Greco S, Benetti A, Cosentini R, Ferrero P. Acute myocarditis as first presentation of severe ulcerative colitis in a young man. Multidisciplinary management and long-term follow-up. J Cardiol Cases. 2022, 26:46-50. 10.1016\/j.jccase.2022.02.008","journal-title":"J Cardiol Cases"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa508","article-title":"Mesalazine-induced myopericarditis: a case report","volume":"5","author":"Shergill S","year":"2021","unstructured":"Shergill S. Mesalazine-induced myopericarditis: a case report. Eur Heart J Case Rep. 2021, 5:ytaa508. 10.1093\/ehjcr\/ytaa508","journal-title":"Eur Heart J Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51554","article-title":"Ulcerative colitis and acute perimyocarditis","volume":"216","author":"Cho KK","year":"2022","unstructured":"Cho KK, Ko Y, Nilsen K, Verdon C, Femia G. Ulcerative colitis and acute perimyocarditis. Med J Aust. 2022, 216:559-61. 10.5694\/mja2.51554","journal-title":"Med J Aust"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22794","article-title":"Acute myopericarditis in the setting of Crohn's colitis: challenging management decisions","volume":"14","author":"Daloya J","year":"2022","unstructured":"Daloya J, Ashraf A, Kaell A, Perera R, Korlipara G. Acute myopericarditis in the setting of Crohn's colitis: challenging management decisions. Cureus. 2022, 14:e22794. 10.7759\/cureus.22794","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2016.4016\/2015","article-title":"Mesalamine-induced myopericarditis - a case report","volume":"108","author":"Bernardo S","year":"2016","unstructured":"Bernardo S, Fernandes SR, Ara\u00fajo-Correia L. Mesalamine-induced myopericarditis - a case report. Rev Esp Enferm Dig. 2016, 108:753-6. 10.17235\/reed.2016.4016\/2015","journal-title":"Rev Esp Enferm Dig"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v15.i11.553","article-title":"Cardiovascular implications of inflammatory bowel disease: an updated review","volume":"15","author":"Bhardwaj A","year":"2023","unstructured":"Bhardwaj A, Singh A, Midha V, Sood A, Wander GS, Mohan B, Batta A. Cardiovascular implications of inflammatory bowel disease: an updated review. World J Cardiol. 2023, 15:553-70. 10.4330\/wjc.v15.i11.553","journal-title":"World J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79207-z","article-title":"Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease","volume":"10","author":"Matsumoto S","year":"2020","unstructured":"Matsumoto S, Mashima H. Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease. Sci Rep. 2020, 10:22176. 10.1038\/s41598-020-79207-z","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.970597","article-title":"Analysis of clinical characteristics of mesalazine-induced cardiotoxicity","volume":"13","author":"Chen J","year":"2022","unstructured":"Chen J, Duan T, Fang W, Liu S, Wang C. Analysis of clinical characteristics of mesalazine-induced cardiotoxicity. Front Pharmacol. 2022, 13:970597. 10.3389\/fphar.2022.970597","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/332772-mesalazine-induced-myocarditis-in-inflammatory-bowel-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:41:24Z","timestamp":1738186884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/332772-mesalazine-induced-myocarditis-in-inflammatory-bowel-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.78208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}